O’Melveny represented RemeGen Co. on the deal.RemeGen Co., Ltd. (“RemeGen”) (9995.HK; 688331.SH) announced its A-share listing on the Sci-Tech Innovation Board of the Shanghai Stock Exchange….
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
